Commentary

You have full text access to this OnlineOpen article

Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas

Changing the paradigms of treatments?

  1. Morton Coleman MD1,†,*,
  2. Lale Kostakoglu MD2

Article first published online: 24 AUG 2006

DOI: 10.1002/cncr.22178

Issue

Cancer

Cancer

Volume 107, Issue 7, pages 1425–1428, 1 October 2006

Additional Information

How to Cite

Coleman, M. and Kostakoglu, L. (2006), Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas. Cancer, 107: 1425–1428. doi: 10.1002/cncr.22178

Author Information

  1. 1

    Center for Lymphoma and Myeloma, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York

  2. 2

    Department of Radiology, Mount Sinai Medical Center, New York, New York

  1. †

    Fax: (212) 734-9238

*Division of Hematology/Oncology, New York Presbyterian Hospital, Weill Cornell Medical Center, 407 East 70th Street, 3rd Floor, New York, NY 10021

Publication History

  1. Issue published online: 18 SEP 2006
  2. Article first published online: 24 AUG 2006
  3. Manuscript Accepted: 27 JUN 2006
  4. Manuscript Revised: 21 JUN 2006
  5. Manuscript Received: 26 APR 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (68K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stephan D. Voss, Oncology of Infancy and Childhood, 2009,

    CrossRef

  2. 2
    T. C. Kwee, R. M. Kwee, R. A. J. Nievelstein, Imaging in staging of malignant lymphoma: a systematic review, Blood, 2008, 111, 2, 504

    CrossRef

  3. 3
    G. Moulin-Romsee, K. Spaepen, S. Stroobants, L. Mortelmans, Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET, European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, 6, 1074

    CrossRef

  4. 4
    M. Hoffmann, M. Raderer, Malignant B-cell Lymphoma, WHO Classification and the Respective 18F-fluoro-deoxy-glucose Positron Emission Tomography Results, Imaging Decisions MRI, 2007, 10, 4
    Direct Link:
  5. 5
    Joachim Yahalom, Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: A randomized study caveat, Leukemia & Lymphoma, 2007, 48, 9, 1667

    CrossRef

  6. 6
    Lale Kostakoglu, Stanley J. Goldsmith, John P. Leonard, Paul Christos, Richard R. Furman, Tamer Atasever, Angely Chandramouly, Sumeet Verma, Pratichi Kothari, Morton Coleman, FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease, Cancer, 2006, 107, 11
    Direct Link:
View Full Article (HTML) Get PDF (68K)